Clinical trial
Observational Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands
NCT02875184 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 6, 2017
- Completion date
- June 30, 2022
- Enrollment
- 200 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.